BioSpace Movers & Shakers, Nov. 6
The Pharma Data
NOVEMBER 5, 2020
has been appointed to the additional role of president and will oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke. Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline. from 1993 to 1995. Dillon is a former St.
40 
Let's personalize your content